Company Filing History:
Years Active: 2024-2025
Title: The Innovative Contributions of Anna Säll
Introduction
Anna Säll is a prominent inventor based in Lund, Sweden. She has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of three patents to her name, Anna's work focuses on innovative solutions for cancer treatment.
Latest Patents
Anna Säll's latest patents include groundbreaking inventions in the realm of bispecific polypeptides. One of her notable inventions relates to novel bispecific polypeptides, such as antibodies, and their application in treating cancers that express carcinoembryonic antigen (CEA). Another significant patent involves bispecific polypeptides that comprise a first binding domain capable of binding specifically to CD137, along with a second binding domain that targets a tumor cell-associated antigen. These inventions also encompass pharmaceutical compositions and their uses in medicine.
Career Highlights
Anna is currently associated with Alligator Bioscience AB, where she continues to push the boundaries of cancer research and treatment. Her work has garnered attention for its potential to improve therapeutic outcomes for patients suffering from various forms of cancer.
Collaborations
Throughout her career, Anna has collaborated with esteemed colleagues, including Peter Ellmark and Laura Varas. These partnerships have further enhanced her research and development efforts in the field of biotechnology.
Conclusion
Anna Säll's innovative contributions to cancer treatment through her patents and collaborations highlight her significant role in advancing medical science. Her work continues to inspire and pave the way for future breakthroughs in the field.